NCT02052999View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Erythematotelangiectatic RosaceaPapulopustular Rosacea
Interventions
DRUG

PAC-14028 cream 1%

Participants received topical PAC-14028 cream 1% twice daily for 8 weeks

OTHER

Vehicle

Participants received topical Vehicle twice daily for 8 weeks

DRUG

Rozex gel 0.75%

Participants received topical Rozex gel 0.75% twice daily for 8 weeks

Trial Locations (1)

Unknown

Chung-Ang University Hospital, Seoul

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02052999 - Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients | Biotech Hunter | Biotech Hunter